You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 48 No. 10, October 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Improved Recognition of Leukoaraiosis and Cognitive Impairment in Alzheimer's Disease

J. Fernando Diaz, MD; Harold Merskey, DM; Vladimir C. Hachinski, MD; Donald H. Lee, MD; Mary Boniferro, MEd; Cindy J. Wong, MSc; Thomas R. Mirsen, MD; Hannah Fox, MBBS

Arch Neurol. 1991;48(10):1022-1025.


Abstract

• We identified 85 patients in a longitudinal study of dementia who had uncomplicated Alzheimer's disease and in whom computed tomography of the head and psychometric testing were conducted within a 6-month period following their entry into the study. Thirty-four patients (40%) had leukoaraiosis, which was disproportionately common in female patients (62% vs 15% in male patients). Analysis of covariance demonstrated a relative reduction of scores on the Extended Scale for Dementia in those patients who had leukoaraiosis, after adjusting for the confounding effects of age, sex, educational level, and duration of illness. Leukoaraiosis was also much more common in women, even after adjusting for the possible confounding effects of age, duration of illness, Extended Scale for Dementia score, and hypertension. Multiple regression analysis showed that leukoaraiosis accounted for 11.6% of the variance of the Extended Scale for Dementia scores. Leukoaraiosis, together with duration of illness, accounted for 18.2% of the variance. Leukoaraiosis is associated with a greater degree of cognitive impairment in patients with Alzheimer's disease.



Author Affiliations

From the Departments of Psychiatry (Drs Diaz, Merskey, and Fox and Ms Boniferro), Clinical Neurological Sciences (Dr Hachinski), and Diagnostic Radiology (Dr Lee), University of Western Ontario, London; the Stroke and Aging Research Group, The John P. Robarts Research Institute, London, Ontario (Dr Hachinski); the Clinical Trials Resources Group, London, Ontario (Dr Wong); and Cooper Hospital, University Medical Center, University of Medicine and Dentistry of New Jersey, Camden (Dr Mirsen). Dr Hachinski is a career investigator with the Heart and Stroke Foundation of Ontario.


Footnotes

Accepted for publication March 28, 1991.

Reprint requests to the Department of Research, London Psychiatric Hospital, 850 Highbury Ave, PO Box 2532, London, Ontario, Canada N6A 4H1 (Dr Merskey).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Cerebrovascular Pathology in Alzheimer's Disease and Its Influence on Clinical Variables
Modrego et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2008;23:91-96.
ABSTRACT  

Impact of White Matter Changes on Clinical Manifestation of Alzheimer's Disease : A Quantitative Study
Hirono et al.
Stroke 2000;31:2182-2188.
ABSTRACT | FULL TEXT  

What Is the Significance of Leukoaraiosis in Patients With Acute Ischemic Stroke?
Wiszniewska et al.
Arch Neurol 2000;57:967-973.
ABSTRACT | FULL TEXT  

Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease
Sawada et al.
J. Neurol. Neurosurg. Psychiatry 2000;68:653-656.
ABSTRACT | FULL TEXT  

A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality
Skoog et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:37-43.
ABSTRACT | FULL TEXT  

Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease
Starkstein et al.
J. Neurol. Neurosurg. Psychiatry 1997;63:66-73.
ABSTRACT | FULL TEXT  

Association of Dementia Severity With Cortical Gray Matter and Abnormal White Matter Volumes in Dementia of the Alzheimer Type
Stout et al.
Arch Neurol 1996;53:742-749.
ABSTRACT  

Computed Tomography--but Not Magnetic Resonance Imaging--Identified Periventricular White-Matter Lesions Predict Symptomatic Cerebrovascular Disease in Probable Alzheimer's Disease
Lopez et al.
Arch Neurol 1995;52:659-664.
ABSTRACT  

The Significance of Cerebral White Matter Abnormalities 100 Years After Binswanger's Report : A Review
Pantoni and Garcia
Stroke 1995;26:1293-1301.
ABSTRACT | FULL TEXT  

Leukoaraiosis in Stroke Patients : The Copenhagen Stroke Study
Jorgensen et al.
Stroke 1995;26:588-592.
ABSTRACT | FULL TEXT  

Patterns of Deterioration in Senile Dementia of the Alzheimer Type
Helmes et al.
Arch Neurol 1995;52:306-310.
ABSTRACT  

Clinical Correlates of Alzheimer's Disease With and Without Silent Radiographic Abnormalities
Marder et al.
Arch Neurol 1995;52:146-151.
ABSTRACT  

Lack of Difference in Brain Hyperintensities Between Patients With Early Alzheimer's Disease and Control Subjects
Erkinjuntti et al.
Arch Neurol 1994;51:260-268.
ABSTRACT  

Neuropsychological Importance of Subcortical White Matter Hyperintensity
Tupler et al.
Arch Neurol 1992;49:1248-1252.
ABSTRACT  

Neuropsychiatric Correlates of Cerebral White-Matter Radiolucencies in Probable Alzheimer's Disease
Lopez et al.
Arch Neurol 1992;49:828-834.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.